Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department

被引:4
作者
Biener, Moritz [1 ]
Giannitsis, Evangelos [1 ]
Thum, Thomas [2 ,3 ,4 ]
Bar, Christian [2 ,3 ]
Stoyanov, Kiril M. [1 ]
Salbach, Christian [1 ]
De Gonzalo-Calvo, David [2 ,5 ,6 ]
Frey, Norbert [1 ]
Mueller-Hennessen, Matthias [1 ]
机构
[1] Univ Klinikum Heidelberg, Klin Kardiol Angiol & Pneumol, Zentrum Innere Med, Heidelberg, Germany
[2] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany
[3] Hannover Med Sch, REBIRTH Ctr Translat Regenerat Med, Hannover, Germany
[4] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany
[5] Univ Hosp Arnau de Vilanova & Santa Maria, IRBLIeida, Translat Res Resp Med, Lleida, Spain
[6] Inst Hlth Carlos III, CIBER Resp Dis CIBERES, Madrid, Spain
关键词
MicroRNA; High sensitivity troponin T; Acute coronary syndrome; Prognosis; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; TERM PROGNOSIS; ARTERY-DISEASE; BIOMARKER; RISK; IMPACT; ESC;
D O I
10.1016/j.clinbiochem.2021.09.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: To evaluate the prognostic value of eleven microRNAs (miRNAs) compared to high-sensitivity Troponin T (hs-cTnT) in patients presenting with suspected acute coronary syndrome (ACS) to the emergency department (ED). Methods: 1,042 patients presenting between August 2014 and April 2017 were included. Expression levels of eleven microRNAs (miR-21-5p, miR-22-3p, miR-29a-3p, miR-92a-3p, miR-122-5p, miR-126-3p, miR-132-3p, miR-133a-3p, miR-134-5p, miR-191-3p, and miR-423-5p) were determined using RT-qPCR. All-cause mortality (ACM) and a composite of ACM, acute myocardial infarction (AMI) and stroke were defined as endpoints. Results: During a median follow-up of 399 (P25-P75: 381-525) days 58 patients (5.6%) died. The composite endpoint occurred in 86 patients (8.3%). Different expression levels of miR-21-5p (median, P25-P75: 5.28 [5.14-5.51] vs. 5.16 [4.97-5.35], p = 0.0033) and miR-122-5p (median, P25-P75: 5.17 [4.81-5.49] vs. 5.35 [5.01-5.69], p = 0.0184) were observed in patients who died compared to survivors. ROC-optimized cutoff of miR-21-5p (HR, P25-P75: 3.3 [1.2-9.4], p = 0.0239), but not miR-122-5p (HR, P25-P75: 0.4 [0.2-0.8], p = 0.0116), was predictive for all-cause mortality, even after adjustment in a multivariate model. Nevertheless, addition of miR-21-5p and miR-122-5p decreased prognostic accuracy of hs-cTnT for all-cause mortality (oAUC: 0.112, p = 0.0159). Hs-cTnT admission values had a high prognostic value for ACM (AUC [95%CI] = 0.794 [0.751-0.837]) and the composite of ACM, AMI and stroke (AUC [95%CI] = 0.745 [0.695-0.794]). Conclusions: Despite a different expression depending on outcomes miR-21-5p and miR-122-5p do not add prognostic information to hs-cTnT in patients presenting with suspected ACS to the ED.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 37 条
[1]  
[Anonymous], 2021, Eur Heart J, V42, P1908, DOI 10.1093/eurheartj/ehaa895
[2]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]  
Biener M., 2021, EUR HEART J-ACUTE CA
[4]   Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease [J].
Biener, Moritz ;
Giannitsis, Evangelos ;
Lamerz, Judith ;
Mueller-Hennessen, Matthias ;
Vafaie, Mehrshad ;
Katus, Hugo A. .
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (06) :409-418
[5]   Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction [J].
Cortez-Dias, Nuno ;
Costa, Marina C. ;
Carrilho-Ferreira, Pedro ;
Silva, Doroteia ;
Jorge, Claudia ;
Calisto, Carina ;
Pessoa, Teresa ;
Martins, Susana Robalo ;
de Sousa, Joao Carvalho ;
da Silva, Pedro Canas ;
Fiuza, Manuela ;
Diogo, Antonio Nunes ;
Pinto, Fausto J. ;
Enguita, Francisco J. .
CIRCULATION JOURNAL, 2016, 80 (10) :2183-+
[6]   Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease [J].
de Boer, Hetty C. ;
van Solingen, Coen ;
Prins, Jurrien ;
Duijs, Jacques M. G. J. ;
Huisman, Menno V. ;
Rabelink, Ton J. ;
van Zonneveld, Anton Jan .
EUROPEAN HEART JOURNAL, 2013, 34 (44) :3451-3457
[7]   Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids [J].
de Gonzalo-Calvo, David ;
Martinez-Camblor, Pablo ;
Baer, Christian ;
Duarte, Kevin ;
Girerd, Nicolas ;
Fellstrom, Bengt ;
Schmieder, Roland E. ;
Jardine, Alan G. ;
Massy, Ziad A. ;
Holdaas, Hallvard ;
Rossignol, Patrick ;
Zannad, Faiez ;
Thum, Thomas .
THERANOSTICS, 2020, 10 (19) :8665-8676
[8]   Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine? [J].
de Gonzalo-Calvo, David ;
Vea, Angela ;
Bar, Christian ;
Fiedler, Jan ;
Couch, Liam S. ;
Brotons, Carlos ;
Llorente-Cortes, Vicenta ;
Thum, Thomas .
EUROPEAN HEART JOURNAL, 2019, 40 (20) :1643-+
[9]  
diaeresis>anninen M. H <spacing, 2020, INT J MOL SCI
[10]   Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) [J].
Fox, Keith A. A. ;
Dabbous, Omar H. ;
Goldberg, Robert J. ;
Pieper, Karen S. ;
Eagle, Kim A. ;
Van de Werf, Frans ;
Avezum, Alvaro ;
Goodman, Shaun G. ;
Flather, Marcus D. ;
Anderson, Frederick A., Jr. ;
Granger, Christopher B. .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7578) :1091-1094